Lv2
114 积分 2025-03-24 加入
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies
5天前
已完结
HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast Cancer
6天前
已完结
Proximity-guided graph learning reveals tumour-associated proximity antigens
7天前
已完结
GPNMB-directed CAR-T cell therapies for solid tumors
20天前
已完结
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors
21天前
已完结
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
25天前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
1个月前
已完结
PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label single‐arm phase 2 study
1个月前
已完结
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
1个月前
已完结
CD70-targeted cancer theranostics: Progress and challenges
1个月前
已完结
皖公网安备34019202002308
